Delayed-start analysis for demonstrating disease modification of solanezumab.

ABSTRACT:

SUBMITTER: Wolters FJ 

PROVIDER: S-EPMC5975054 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature